Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
-4.29%
Price
18:20
€112.70
Summary
This prediction is currently active. With a performance of -4.29%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.219% | -0.219% |
| iShares Core DAX® | 3,01 % | 1,44 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % |
| iShares S&P 500 | 2,38 % | 0,24 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.90
07.04.26
07.04.26
€209.89
07.04.27
07.04.27
-0.18%
18:20
18:20
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
9.05%
18:20
18:20